attack in Medical Technology

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... (10 versus 2), though fewer deaths from heart attack (7 versus 10) and fewer from stroke (0 versus 5) ... MACE, which includes cardiovascular death, heart attack or stroke (154 events or 6.9 percent versus 165 ... cause death, cardiovascular death, MACE, heart attack and stroke) was statistically significant. ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... of plasma from nine HAE patients experiencing an attack in ViroPharma/Lev's Phase 3 CHANGE (C1 inhibitor ... from nine HAE patients at baseline, during an attack of swelling, and at one, four and 12 hours after ... left unrestricted, can initiate or perpetuate an attack by consuming the already low levels of endogenous ...

Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine

... insight for physicians in treating heart attack patients NATICK, Mass., May 6 ... stents (BMS) for the treatment of heart attack patients, a complicated patient population with ... conclusive data comparing DES and BMS in heart attack patients," continued Dr. Stone. "The findings ...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... an increased risk of cardiovascular death, heart attack or stroke compared with those patients who had ... combined endpoint of cardiovascular death, heart attack or stroke was 8.5 percent (N=407) in those who ... 741,000 deaths in the EU each year.(5) Heart attack is a major manifestation of coronary heart ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

... activated stem cells substantially reduced heart attack related tissue damage (infarct size), caused ... Ad5IGF-1 in myocardial regeneration after a heart attack may be due to IGF-1-induced release of various ... cell therapies aimed at the treatment of heart attack and other indications," stated Cardium's Chief ...

American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks

... of STEMI patients and ultimately all heart attack patients. The association gave the survey ... "EMS systems are the point of entry for all heart attack patients and are extremely important to reducing ... 400,000 people in the U.S. have a type of heart attack known as STEMI, in which blood flow is completely ...

February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus

... . Cardiovascular diseases, including heart attack and stroke, account for 65 percent of all ... are two to four times more likely to have a heart attack than someone without the disease. For a ... with type 2 diabetes, the risk of a future heart attack is the same as that of someone who's already had ...

VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease

... to major adverse cardiac events, including heart attack and stroke. VIA-2291 is designed to be a ... at the baseline as a result of the recent heart attack or unstable angina. In the CEA trial, a ... and its complications, including heart attack and stroke. For more information, visit: ...

Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death

... in the diagnosis and treatment of heart attack patients, prevention of recurrent heart attacks ... higher risk for dying or having another heart attack (in the following three months to four years) compared with patients who did not experience a heart attack during the same initial period. The findings from ...

Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke

... their risk for cardiovascular death, heart attack and stroke, according to new findings from the ... example, the combined endpoint of CV death, heart attack and stroke and/or hospitalization for ... cardiovascular (CV) outcomes (CV death, heart attack and stroke). AF status and one-year follow-up ...

Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System

... to investigate the feasibility of cooling heart attack patients with its ThermoSuit(R) System, the only ... has suggested that cooling of some types of heart attack patients before coronary reperfusion could result ... of the ThermoSuit System in treating heart attack patients. Life Recovery Systems believes that ...

Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years

... Are at Lower Risk of Experiencing Death, a Heart attack or a Repeat Procedure Compared to ... for patients, defined as cardiac death, heart attack (myocardial infarction or MI), or ischemia-driven ... reduction in the risk of all-cause death or heart attack (MI) compared to TAXUS (5.1 percent for XIENCE V ...

American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression

... times more common in patients following a heart attack than in the general community. Heart patients ... 15 percent to 20 percent of hospitalized heart attack patients met the Diagnostic and ... times more common in patients following a heart attack than in the general community," said Judith H. ...

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel

... risk for patients who suffer any form of heart attack by 23 percent compared with clopidogrel (2.9 ... shown to reduce the risk of a future severe heart attack (ST elevation myocardial infarction (STEMI), a ... of the composite of cardiovascular death, heart attack or stroke by 19 percent, with an increased risk ...

Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

... prasugrel substantially reduced risk of heart attack and stent thrombosis compared with clopidogrel ... were 40 percent less likely to suffer a heart attack if they were treated with prasugrel vs. ... rate of cardiovascular death, non-fatal heart attack and non-fatal stroke was reduced by 30 percent in ...

Record 'Door-to-Balloon' Time at Presbyterian Hospital of Dallas

... "Research shows that the quicker a heart attack is treated the less potential damage there is to ... patients." The time it takes to treat a heart attack patient when he or she arrives in a hospital's ER ... Heart Association, have shown that treating heart attack patients within 90 minutes of arrival ...

VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial

... associated with inflammation, including heart attack and stroke. "Analyzing the carotid plaque ... who have experienced a recent heart attack or stroke, and includes measures of leukotrienes, ... and its complications, including heart attack and stroke. The company's lead drug candidate, ...

Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder

... on the incidence of a doxapram-induced panic attack and the effect of AZ-002 on the duration of ... therapy for the acute treatment of a panic attack or an established clinical development ... on the occurrence of a doxapram-induced panic attack of sufficient intensity and a second to assess ...

Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows

... acute heart problems such as heart attack and heart surgery are more likely to develop habits to control heart attack risk factors when they meet regularly with ... received optimal care for controlling heart attack prevention. The goals of ...

VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial

... associated with inflammation, including heart attack and stroke. "Completing enrollment in our ... the target population, patients with recent heart attack or unstable angina, and we remain on track to ... with ACS who have experienced a recent heart attack or unstable angina. The study includes measures ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... flow was restored in the heart in a porcine heart attack model. Results from this study demonstrated that ... a heart attack." Rapid & Early Cooling Heart attack Preclinical Study Results This study was ... heart attack. Using a closed-chest porcine heart attack model in which the coronary artery supplying the ...

Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery

... the right reasons: to improve outcomes for heart attack patients and to better serve patients in ... for patients who are experiencing a heart attack -- so-called primary PCI -- but advise against it ... at off-site centers were experiencing a heart attack at the time of PCI, as compared with 29 percent ...

VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial

... associated with inflammation, including heart attack and stroke. The CEA study enrolled 50 patients ... who have experienced a recent heart attack or stroke, and includes measures of leukotrienes, ... and its complications, including heart attack and stroke. The company's lead drug candidate, ...

Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack

... in LTB4 in patients with a history of heart attack or coronary artery disease and who were taking a ... of these genes confer increased risk of heart attack by increasing the production of the ... LTB4. DG051 is designed to decrease risk of heart attack by decreasing the production of LTB4. About ...

VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation

... associated with inflammation, including heart attack and stroke. The FDG-PET trial is one of ... address the major adverse events, including heart attack and stroke, associated with this disease. Despite ... approximately 50 patients following a heart attack into a 24 week randomized, double blind, ...

News from the American Heart Association

... trial data on a variety of aspects of heart attack care has prompted the American College of ... guidelines for treating the type of heart attack called ST elevation myocardial infarction ... trial data on a variety of aspects of heart attack care has prompted the American College of ...

Interview of the Vice President

... be significantly more at risk for a terrorist attack if they were to prevail in the fight in Iraq, ... But I think six-and-a-half years without another attack succeeding against the United States is a ... explosives onboard aircraft and to do a major attack on several flights at once within a really ...

Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels

... plaques pro-actively, before a major heart attack can occur. Prescient is actively working with ... coronary plaques are at risk of causing a heart attack or other coronary event. Prescient Medical plans ... over one million of them will suffer a heart attack caused by the sudden rupture of soft plaque ...

deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack

... at double the risk of suffering an early heart attack -- before the age of 50 in men and 60 in women -- ... heart attack. While many risk factors for heart attack are understood, the disease remains the leading ... cases -- men and women who suffered a heart attack before the ages of 50 and 60, respectively -- ...

deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack

... of DG051 in patients with a history of heart attack or coronary artery disease. The Phase IIa is a ... of these genes confer increased risk of heart attack by increasing the production of the ... LTB4. DG051 is designed to decrease risk of heart attack by decreasing the production of LTB4. About ...

FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function

... of therapies. "When an individual has a heart attack with a significant region of the heart muscle damaged, recovery to pre-heart attack levels are rarely achieved," said Lemanski. ... therefore enable them to return to pre-heart attack activity levels. In addition, children who are ...

Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation

... potentially lethal blood clots causing heart attack and stroke. "By identifying mechanisms ... and blockage of vital blood vessels during heart attack or stroke. "Life-threatening cardiovascular events, such as heart attack and stroke, occur when plaque or fatty deposits ...

Many Heart Attack Patients Don't Get Best Emergency Treatment

... -- Far more of today's heart attack patients receive emergency angioplasty treatment ... was highest among those patients whose heart attack symptoms don't include typical symptoms like ... from 238,291 patients who had had a type of heart attack for which this therapy is appropriate between ...

St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures

... quality of life for patients. St. Francis created the Emergency Heart attack Response Team (EHART) protocol, which has revolutionized heart attack treatment in the United States and abroad. St. Francis has the only 24/7 ...

VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease

... attack, stroke and cardiovascular mortality in patients with recent heart attack and/or established atherosclerotic cardiovascular disease. Guidance from ... underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of drug candidates includes other ...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

... the patients studied in BARI-2D faced only a small risk of death or heart attack to begin with, it stands to reason that revascularization would not show ... were on medications that can pose significant risks, including heart attack and heart failure, or could have faced complications from combining ...

New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug

... Four of the most commonly used proton pump inhibitors raise risk of heart attack and stroke for patients taking Plavix(R) and increase healthcare costs ... and the known benefits of clopidogrel in reducing the risk of death, heart attack and stroke after coronary stenting, patients and their physicians should ...

New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity

... many people at risk for potentially life-threatening events such as heart attack or stroke. Results of the analysis were presented today at the American ... shown that unhealthy levels of triglycerides and HDL can lead to heart attack and stroke," said study author Jerome D. Cohen, M.D., chairman of the ...

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study

... or CV death was reduced by nearly half (47%, p -- risk of heart attack was cut by more than half (54%, p -- risk of stroke was cut by nearly ... and has now demonstrated a nearly 50% reduction in the risk of heart attack and stroke in a population of patients who had elevated hsCRP but low to ...

VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial

... major adverse cardiac events associated with inflammation, including heart attack and stroke. The ACS principal study enrolled 191 patients, including ... underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple ...